Literature DB >> 8440198

Serum factors induce messenger ribonucleic acid levels for cellular retinol-binding protein in rat Sertoli cells.

C F Kroepelien1, H K Knutsen, T B Haugen, V Hansson, W Eskild.   

Abstract

This report shows that serum factors dramatically increase the levels of mRNA for cellular retinol-binding protein (CRBP) in cultured rat Sertoli cells. Incubation of rat Sertoli cells (0-24 h) with 10% fetal calf serum (FCS) was associated with a time-dependent increase in CRBP mRNA levels. A significant increase (6-fold) was observed after 3 h of incubation. Maximal levels (15- to 50-fold) were reached after 9-12 h and were maintained for as long as serum was present. The effect was concentration dependent, with maximal induction at 10% FCS. Removal of FCS resulted in a decline in the CRBP mRNA levels, with a t1/2 of approximately 7 h. The CRBP mRNA stimulating activity (CMSA) was completely removed from FCS by precipitation with 5% trichloroacetic acid, but was only partly (50%) inhibited by heating at 100 C or trypsin treatment. Removal of retinol from FCS by repeated ether extractions did not alter the CMSA of FCS. Both the induction and degradation of CRBP mRNA were inhibited by the protein synthesis inhibitor cycloheximide. A nuclear protein binding to the 5'-flanking region of the CRBP gene was detected in nuclear extracts from untreated Sertoli cells, but not in nuclear extracts from Sertoli cells treated with 10% FCS for 3 h. Thus, serum factors, different from retinoids, dramatically stimulate the levels of CRBP mRNA in rat Sertoli cells. This is associated with the loss of protein binding to the 5'-flanking region of the CRBP gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440198     DOI: 10.1210/endo.132.3.8440198

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  Human NCU-G1 can function as a transcription factor and as a nuclear receptor co-activator.

Authors:  Knut R Steffensen; Mariam Bouzga; Frode Skjeldal; Cecilie Kasi; Almira Karahasan; Vilborg Matre; Oddmund Bakke; Sylvain Guérin; Winnie Eskild
Journal:  BMC Mol Biol       Date:  2007-11-16       Impact factor: 2.946

2.  Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer.

Authors:  Alice Arapshian; Silvina Bertran; Yuvarani S Kuppumbatti; Shigeo Nakajo; Rafael Mira-y-Lopez
Journal:  Mol Cancer       Date:  2004-04-27       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.